Heart disease is the leading cause of death in the U.S., and experts warn that Covid-19’s effects on the heart may cement that ranking for years to come.
Researchers at OMRF helped develop a drug that brings relief to patients with sickle cell disease.
OMRF and Stanford have received a four-year grant to use zebrafish to study how small genetic variations can lead to several human diseases.
Adakveo, a drug based on the discoveries of OMRF VP of Research Rodger McEver, is relieving pain for Danielle Jamison and others with sickle cell around the world.
OU Health has been awarded a $5.3 million federal grant to continue a partnership with OMRF and the VA on research into the biology of aging and the role it plays in the onset of diseases like cancer and diabetes.
Three OMRF scientists were recognized for excellence at this year’s American College of Rheumatology meeting.